Salidroside exerts anti-tumor effects in ovarian cancer by inhibiting STAT3/c-Myc pathway-mediated glycolysis. Biomol Biomed [Internet]. 2024 Dec. 11 [cited 2025 Jan. 21];25(1):82–93. Available from: https://bjbms.org/ojs/index.php/bjbms/article/view/10867